NCT02414230View on ClinicalTrials.gov

F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

September 19, 2016

Study Completion Date

June 10, 2020

Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
DRUG

Drug: F 18 T807

Participants will receive a single intravenous bolus injection of approximately 6.5-10mCi (240-370MBq) of F 18 T807. For those who cannot tolerate the full exam, participants will receive single intravenous bolus injection of approximately 6.5-10mCi (240-370MBq) of F 18 T807.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Tammie L. S. Benzinger, MD, PhD

OTHER

NCT02414230 - F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter